{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:58:27Z","timestamp":1790402307546,"version":"4.1.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T00:00:00Z","timestamp":1558310400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T00:00:00Z","timestamp":1558310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s12022-019-9579-2","type":"journal-article","created":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T10:52:17Z","timestamp":1558435937000},"page":"163-167","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Pembrolizumab-Induced Thyroiditis"],"prefix":"10.1007","volume":"30","author":[{"given":"Brittney A.","family":"Imblum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zubair W.","family":"Baloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Fraker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia A.","family":"LiVolsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,20]]},"reference":[{"issue":"1","key":"9579_CR1","first-page":"1","volume":"3","author":"E Rossi","year":"2016","unstructured":"Rossi, E., Sgambato, A., De Chiara, G., Ciardiello, F., & Gridelli, C. (2016). Thyroid-Induced Toxicity of Check-Point Inhibitors Immunotherapy in the Treatment of Advanced Non-Small Cell Lung Cancer. Journal of Endocrinology and Diabetes, 3(1): 1\u201310.","journal-title":"Journal of Endocrinology and Diabetes"},{"issue":"5","key":"9579_CR2","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1210\/jc.2014-4560","volume":"100","author":"S Orlov","year":"2015","unstructured":"Orlov, S., Salari, f., Kashat, L., & Walfish, P. Induction of Painless Thyroiditis in Patients Receiving Programmed Death 1 Receptor Immunotherapy for Metastatic Malignancies. (2015). J Clin Endocrinol Metab, 100(5): 1738\u20131741.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"9579_CR3","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1080\/21645515.2016.1199310","volume":"12","author":"G Kwok","year":"2016","unstructured":"Kwok, G., Yau, T., Chiu, J., Tse, E., & Kwong, Y. Pembrolizumab (Keytruda). (2016). Human Vaccines & Immunotherapeutics, 12(11): 2777\u20132789.","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"22","key":"9579_CR4","doi-asserted-by":"publisher","first-page":"31318","DOI":"10.18632\/oncotarget.8698","volume":"7","author":"S Chowdhury","year":"2016","unstructured":"Chowdhury, S., Veyhl, J., Jessa, F., Polyakova, O., Alenzi, A., MacMillan, C., Ralhan, R., & Walfish, P. Programmed death-ligand 1 overexpression is a prognostic marker for aggressive papillary thyroid cancer and its variants. (2016). Oncotarget, 7(22): 31318\u201332328.","journal-title":"Oncotarget"},{"issue":"11","key":"9579_CR5","doi-asserted-by":"publisher","first-page":"4431","DOI":"10.1210\/jc.2016-2300","volume":"101","author":"J Filette","year":"2016","unstructured":"Filette, J., Jansen, Y., Schreuer, M., Hendrik, E., Velkeniers, B., Neyns, B., & Bravenboer, B. (2016). Incidence of Thyroid-Related Adverse Events in Melanoma Patients Treated with Pembrolizumab. J Clin Endocrinol Metab, 101(11): 4431\u20134439.","journal-title":"J Clin Endocrinol Metab"},{"key":"9579_CR6","doi-asserted-by":"crossref","unstructured":"Lomax, A., Lim, J., Cheng, R., Sweeting, A., Lowe, P., McGill, N., Shackel, N., Chua, E., & McNeil, C. Immune Toxicity with Checkpoint Inhibition for Metastatic Melanoma: Case Series and Clinical Management. (2018). Journal of Skin Cancer.","DOI":"10.1155\/2018\/9602540"},{"key":"9579_CR7","doi-asserted-by":"crossref","unstructured":"Lubin, D., Baraban, E., Lisby, A., Jalali-Farahani, S., Zhang, P., & Livolsi, V. Papillary Thyroid Carcinoma Emerging from Hashimoto Thyroiditis Demonstrates Increased PD-L1 Expression, Which Persists with Metastasis. (2018). Endocrine Pathology.","DOI":"10.1007\/s12022-018-9540-9"},{"key":"9579_CR8","doi-asserted-by":"publisher","first-page":"6738","DOI":"10.4049\/jimmunol.181.10.6738","volume":"181","author":"A Kinter","year":"2008","unstructured":"Kinter, A., Godbout, E., McNally, J., Sereti, I., Roby, G., O\u2019Shea, M., & Fauci, A. The Common \u01b4-Chain Cytokines IL-2, IL-7, IL-15, and IL-21 Induce the Expression of Programmed Death-1 and Its Ligands. (2008). The Journal of Immunology, 181: 6738\u20136746","journal-title":"The Journal of Immunology"},{"key":"9579_CR9","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/eji.201040979","volume":"41","author":"S Wolfle","year":"2011","unstructured":"Wolfle, S., Strebovsky, J., Bartz, H., Sahr, A., Arnold, C., Kaiser, C., Dalpke, A., & Heeg, K. PD-L1 expression on tolerogenic APCs is controlled by STAT-3. (2011). Eur J Immunol., 41: 413\u2013424.","journal-title":"Eur J Immunol."},{"key":"9579_CR10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1126\/scitranslmed.3003689","volume":"4","author":"J Taube","year":"2012","unstructured":"Taube, J., Anders, R., Young, G., Xu, H., Sharma, R., McMiller, T., Chen, S., Klein, A., Pardoll, D., Topalian, S., and Chen, L. Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape. (2012). Sci Transl Med, 4: 127\u2013137.","journal-title":"Sci Transl Med"},{"issue":"1","key":"9579_CR11","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1530\/ERC-12-0313","volume":"20","author":"L Cunha","year":"2013","unstructured":"Cunha, L., Marcello, M., Morari, E., Nonogaki, S., Conte, F., Gerhard, Rn., Soares, F., Vassallo, J., & Ward, L. (2013). Differentiated thyroid carcinomas may elude the immune system by B7H1 upregulation. Endocrine-Related Cancer, 20(1): 103\u2013110.","journal-title":"Endocrine-Related Cancer"},{"issue":"2","key":"9579_CR12","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1001\/jamaoncol.2017.3064","volume":"4","author":"R Barroso-Sousa","year":"2018","unstructured":"Barroso-Sousa, R., Barry, W., Garrido-Castro, A., Hodi, S., Min, L., Krop, I., & Tolaney, S. Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpiont Inhibitor Regimens: A Systematic Review and Meta-Analysis. (2018). JAMA Oncology, 4(2): 173\u2013182.","journal-title":"JAMA Oncology"},{"issue":"26","key":"9579_CR13","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1056\/NEJMra021194","volume":"348","author":"E Pearce","year":"2003","unstructured":"Pearce, E., Farwell, A., & Baverman, L. Thyroiditis. (2003). New England Journal of Medicine, 348(26): 2646\u20132655.","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"9579_CR14","doi-asserted-by":"publisher","first-page":"127","DOI":"10.4158\/EP11373.CR","volume":"18","author":"A Carluccio","year":"2012","unstructured":"Carluccio, A., Sundaram, N., Yanagisawa, R., & Tomer, Y. Apathetic Thyrotoxicosis Secondary to Atypical Subacute Thyroiditis. (2012). Endocrine Practice, 18(5): 127\u2013129","journal-title":"Endocrine Practice"},{"issue":"1","key":"9579_CR15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.5603\/EP.a2018.0010","volume":"69","author":"J Daroszewski","year":"2018","unstructured":"Daroszewski, J., Paczkowska, K., Jawiarczyk-Przybylowska, A., Bolanowski, M., and Jelen, M. Anaplastic thyroid carcinoma with rapid thyrotoxicosis \u2013 a case report and the literature review. (2018). Endokrynologia Polska, 69(1): 28\u201331.","journal-title":"Endokrynologia Polska"},{"issue":"8","key":"9579_CR16","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1210\/jc.2017-00448","volume":"102","author":"D Delivanis","year":"2017","unstructured":"Delivanis, D., Gustafson, M., Bornschlegl, S., Merten, M., Kottschade, L., Withers, S., Dietz, A., & Ryder, M. Pembrolizumab-Induced Thyroiditis: Comprehensive Clinical Review and Insights Into Underlying Involved Mechanisms. (2017). J Clin Endocrinol Metab, 102(8): 2770\u20132780.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-019-9579-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12022-019-9579-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-019-9579-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T23:47:02Z","timestamp":1589845622000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12022-019-9579-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,20]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["9579"],"URL":"https:\/\/doi.org\/10.1007\/s12022-019-9579-2","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,20]]},"assertion":[{"value":"20 May 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}